Center-Authored Papers

Filters: Author is Kemp, Christopher J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bailey LS, Gurley KE, Hoon-Kim K, Kelly-Spratt KS, Kemp CJ.  2008.  Tumor suppression by p53 in the absence of Atm.. Molecular cancer research : MCR. 6(7):1185-92. Abstract
Busch SE, Gurley KE, Moser RD, Kemp CJ.  2012.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.. The Journal of pathology. 227(3):298-305. Abstract
D
Diede SJ, Yao Z, Keyes CC, Tyler AE, Dey J, Hackett CS, Elsaesser K, Kemp CJ, Neiman PE, Weiss WA et al..  2013.  Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer.. Epigenetics : official journal of the DNA Methylation Society. 8(12):1254-60. Abstract
F
Fero ML, Kemp CJ.  2002.  p27 (Kip1) . The Encylopedia of Molecular Medicine. :2363-2366.
G
Gerhard DS, Clemons PA, Shamji AF, Hon C, Wagner BK, Schreiber SL, Krasnitz A, Sordella R, Sander C, Lowe SW et al..  2016.  Transforming Big Data into cancer-relevant insight: An initial, multi-tier approach to assess reproducibility and relevance.. Molecular cancer research : MCR. Abstract
Glover CE, Gurley KE, Kim K-H, Storer BE, Fero ML, Kemp CJ.  2009.  Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancer.. Carcinogenesis. 30(6):1058-63. Abstract
Grosse-Wilde A, Kemp CJ.  2008.  Metastasis suppressor function of tumor necrosis factor-related apoptosis-inducing ligand-R in mice: implications for TRAIL-based therapy in humans? Cancer research. 68(15):6035-7. Abstract
Gurley KE, Moser RD, Kemp CJ.  2015.  Induction of Liver Tumors in Mice with N-Ethyl-N-Nitrosourea or N-Nitrosodiethylamine.. Cold Spring Harbor protocols. 2015(10):pdb.prot077438. Abstract
Gurley KE, Moser RD, Kemp CJ.  2015.  Induction of Colon Cancer in Mice with 1,2-Dimethylhydrazine.. Cold Spring Harbor protocols. 2015(9):pdb.prot077453. Abstract
Gurley KE, Ashley AK, Moser RD, Kemp CJ.  2017.  Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation.. Cell death and differentiation. Abstract
Gurley KE, Moser RD, Kemp CJ.  2015.  Induction of Lung Tumors in Mice with Urethane.. Cold Spring Harbor protocols. 2015(9):pdb.prot077446. Abstract
Gurley KE, Moser R, Gu Y, Hasty P, Kemp CJ.  2009.  DNA-PK suppresses a p53-independent apoptotic response to DNA damage.. EMBO reports. 10(1):87-93. Abstract
H
Huang J-W, Wang Y, Dhillon KK, Calses P, Villegas E, Mitchell PS, Tewari M, Kemp CJ, Taniguchi T.  2013.  Systematic Screen Identifies miRNAs that Target RAD51 and RAD51D to Enhance Chemosensitivity.. Molecular cancer research : MCR. 11(12):1564-73. Abstract
K
Kelly-Spratt KS, Philipp-Staheli J, Gurley KE, Hoon-Kim K, Knoblaugh SE, Kemp CJ.  2009.  Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.. Oncogene. 28(41):3652-62. Abstract
Kelly-Spratt KS, Kasarda EA, Igra M, Kemp CJ.  2008.  A mouse model repository for cancer biomarker discovery.. Journal of proteome research. 7(8):3613-8. Abstract
Kelly-Spratt KS, Pitteri SJ, Gurley KE, Liggitt D, Chin A, Kennedy J, Wong C-H, Zhang Q, Busald Buson T, Wang H et al..  2011.  Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.. PloS one. 6(5):e19721. Abstract
Kemp CJ, Moore JM, Moser R, Bernard B, Teater M, Smith LE, Rabaia NA, Gurley KE, Guinney J, Busch SE et al..  2014.  CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer.. Cell reports. 7(7):1020-9. Abstract
Kemp CJ.  2015.  Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years.. Cold Spring Harbor protocols. 2015(10):pdb.top069906. Abstract
Kemp CJ, Grandori C.  2013.  Functional genomics to identify unforeseen cancer drug targets.. Future oncology (London, England). 9(4):473-6.
M
Mishra R, Watanabe T, Kimura MT, Koshikawa N, Ikeda M, Uekusa S, Kawashima H, Wang X, Igarashi J, Choudhury D et al..  2015.  Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.. Cancer science. 106(4):421-9. Abstract
Moore JM, Rabaia NA, Smith LE, Fagerlie S, Gurley K, Loukinov D, Disteche CM, Collins SJ, Kemp CJ, Lobanenkov VV et al..  2012.  Loss of maternal CTCF is associated with peri-implantation lethality of Ctcf null embryos.. PloS one. 7(4):e34915. Abstract
Moser R, Toyoshima M, Robinson K, Gurley KE, Howie HL, Davison J, Morgan M, Kemp CJ, Grandori C.  2012.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.. Molecular cancer research : MCR. 10(4):535-45. Abstract
Moser R, Xu C, Kao M, Annis J, Lerma LA, Schaupp CM, Gurley KE, Jang IS, Biktasova A, Yarbrough WG et al..  2014.  Functional kinomics identifies candidate therapeutic targets in head and neck cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(16):4274-88. Abstract
P
Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R et al..  2017.  Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.. Cancer discovery. Abstract
Payne SR, Zhang S, Tsuchiya K, Moser R, Gurley KE, Longton G, deBoer J, Kemp CJ.  2008.  p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.. Molecular and cellular biology. 28(1):258-68. Abstract